Gross, Nicole and Geiger, Susi (2023) Covid-19, global solidarity, and the case for equitable vaccine distribution through technology transfers. Public Policy.
Full text not available from this repository.Abstract
The Covid-19 pandemic has highlighted the importance of health technologies to mitigate against the spread of the disease, but it has also demonstrated that the current biopharmaceutical business model, based on patented medicines and other technologies, leads to vast inequalities in healthcare particularly in low- and middle-income countries. We believe that the pharmaceutical industry has a duty to enable and enact global solidarity through technology sharing, but judging by current technology transfer practices, we question their willingness to assume their role in organizing healthcare markets through solidaristic principles. In the absence of a voluntary adoption of solidaristic practices by pharmaceutical firms, solidarity needs to be institutionalized as a fundamental organizing principle for global healthcare markets, particularly in times of health emergencies.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Covid-19 pandemic; technology transfers; solidarity; market organization |
Subjects: | Q Science > QR Microbiology > QR180 Immunology R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine T Technology > Biomedical engineering H Social Sciences > HG Finance > International Finance. International Monetary System |
Divisions: | School of Business > Staff Research and Publications |
Depositing User: | Tamara Malone |
Date Deposited: | 29 Sep 2023 13:46 |
Last Modified: | 29 Sep 2023 13:46 |
URI: | https://norma.ncirl.ie/id/eprint/6856 |
Actions (login required)
View Item |